Concurrent Conference Programs

(Track hopping between programs is encouraged)

June 2-4

Accelerating Target Discovery
CRISPR, Chemical Biology & Phenotypic Screening, Protein Degradation

Expanding Chemical & Druggable Space
Encoded Libraries & Macrocyclics, FBDD & Lead Generation, PROTACs

New Small Molecule Drug Targets
RNA, Immunology & Oncology, Microbiome

Emerging Indications and Modalities
CNS & Neuroscience, Gene and Cell Therapy, Fibrosis and Liver Diseases

Immuno-Oncology Advances
Translational IO, Immune Profiling, Tumor Models 

Disease Modeling
3D Cellular Modeling, iPSCs, Bioengineered Models

Preclinical Strategies, Models & Tools in Oncology
Platforms & Combinations, Novel Therapeutics, Tumor Models

Advances in Drug Metabolism & Safety Testing
Lead Optimization,  Predicting Toxicity, Safety for New Modalities

Immuno-Oncology Biomarkers
Patient Selection, Immune Profiling, Companion Diagnostics

Clinical and Translational Biomarkers
Precision Medicine, Liquid Biopsy, Clinical Trials 

AI for Drug Discovery and Development
Accelerating Drug Discovery - One Use Case At a Time

June 3-4

Drug Discovery Technologies
Enabling Disruptive Innovation